N-Carboxyanhydrides, 1
N-substituted (NNCAs), 395
Carboxylates, 180
Catalyst-transfer, 191
Suzuki–Miyaura coupling
polymerization, 228
Cathepsin B, 178
Cationic ring-opening copolymerization
(CROP), 41
Ceramics, 277
Chain-growth condensation polymerization
(CGCP), 191
Chemical vapor deposition (CVD), 62
Chiral amplification, 123, 131
Chiral derivatising agents (CDAs), 125
2-Chloroethyl vinyl ether (CEVE), 315
[(Chloromethyl)phenyl]ethyl
alkoxyamine, 320
Chlorophenylsulfonyl phenoxide, 195
α-Chymotrypsin, 178, 182
Circular dichroism (CD), 421
Close-packed spheres (CPS), 263
Collagenase, 178
Colloids, 329
Comb polymer, 149
Condensation polymerization, 193
Conformation of the spacer, 109
π-Conjugated polymers, 191
Constant-volume transition entropy, 109
Cook-and-bake method, 83
Copolypeptides 1
hydrogels, 26
vesicles, 20
Copolypeptoids, multiblock, 396
Copolythiophenes, 231
Copper-catalyzed azide-alkyne cycloaddition
(CuAAC), 40, 46, 304
Copper-mediated living radical
polymerization, 41
CuBr/4,4’-di-n-heptyl-2, 2’-bipyridine, 42
Cyclic polymers, 295
Cyclodehydrogenation, 62, 72
Cyclophane, surface cyclodehydrogenation, 79
D
Dendrimerosomes, 365
Dendrimers, 298
self-assembly, 99
Dendritic cell-associated lectin (DC-SIGN), 55
Dendronized polymer, 345
Dendrons, self-assembling, 347
Diels–Alder cycloaddition, 78
Diblock copolypeptides, 19
Difluorophenyl sulfone, 196
Dihydroxyl poly(ethylene oxide) (PEO), 306
3,4-Dihydroxyphenylalanine (DOPA), 246
Dimethylbenzalazine mesogens, 115
2,6-Dimethylphenol, 196
Di(p-toluenesulfonate)-PEO, 306
Disorientation angle, 114
Dispersion, 431
Disulfide linkages, 181
Dithiocarbamates, glycopolymer-based, 54
DNA dumbbell conjugates, 373
DNA-PDI dumbbells, 373
Doxorubicin, 176
Drug delivery, 167
Drug release, 415, 422
Dual-color fluorescence cross-correlation
spectroscopy (DC-FCCS), 334
Dynamic light scattering, 18, 420
E
Elastin, native, 415
ES12, 418
Elastin-BS3 microgels, 418
Elastin-PEG DGE, 418
Electrons/O2, reversible structure/function
switching, 367
Electrostatic self-assembly and covalent
fixation (ESA-CF), 306
Emulsions, 340
solvent evaporation, 329
Encapsulation, 136
Enhanced permeability and retention
(EPR), 170
Enzymatic degradation, 421
Enzymatic polymerization, 141, 153
Epichlorohydrin/EO, 173
Ethyl 3-(alkylamino)benzoate, 204
Ethyl D-/L-lactates (EtLa)s, 159
Ethyl methacrylate (EMA), 147
Ethyl 5-(methylamino)isophthalate, 209
Ethylene oxide (EO), 171
F
Field emission scanning electron microscopy
(FESEM), 420
4-Fluoro-4’-hydroxybenzophenone, 195
4-Fluorophenyl sulfone, 195
Fuel cells, 259, 282
Fullerenes, 100
phospholipids, 100
448
Index
N-substituted (NNCAs), 395
Carboxylates, 180
Catalyst-transfer, 191
Suzuki–Miyaura coupling
polymerization, 228
Cathepsin B, 178
Cationic ring-opening copolymerization
(CROP), 41
Ceramics, 277
Chain-growth condensation polymerization
(CGCP), 191
Chemical vapor deposition (CVD), 62
Chiral amplification, 123, 131
Chiral derivatising agents (CDAs), 125
2-Chloroethyl vinyl ether (CEVE), 315
[(Chloromethyl)phenyl]ethyl
alkoxyamine, 320
Chlorophenylsulfonyl phenoxide, 195
α-Chymotrypsin, 178, 182
Circular dichroism (CD), 421
Close-packed spheres (CPS), 263
Collagenase, 178
Colloids, 329
Comb polymer, 149
Condensation polymerization, 193
Conformation of the spacer, 109
π-Conjugated polymers, 191
Constant-volume transition entropy, 109
Cook-and-bake method, 83
Copolypeptides 1
hydrogels, 26
vesicles, 20
Copolypeptoids, multiblock, 396
Copolythiophenes, 231
Copper-catalyzed azide-alkyne cycloaddition
(CuAAC), 40, 46, 304
Copper-mediated living radical
polymerization, 41
CuBr/4,4’-di-n-heptyl-2, 2’-bipyridine, 42
Cyclic polymers, 295
Cyclodehydrogenation, 62, 72
Cyclophane, surface cyclodehydrogenation, 79
D
Dendrimerosomes, 365
Dendrimers, 298
self-assembly, 99
Dendritic cell-associated lectin (DC-SIGN), 55
Dendronized polymer, 345
Dendrons, self-assembling, 347
Diels–Alder cycloaddition, 78
Diblock copolypeptides, 19
Difluorophenyl sulfone, 196
Dihydroxyl poly(ethylene oxide) (PEO), 306
3,4-Dihydroxyphenylalanine (DOPA), 246
Dimethylbenzalazine mesogens, 115
2,6-Dimethylphenol, 196
Di(p-toluenesulfonate)-PEO, 306
Disorientation angle, 114
Dispersion, 431
Disulfide linkages, 181
Dithiocarbamates, glycopolymer-based, 54
DNA dumbbell conjugates, 373
DNA-PDI dumbbells, 373
Doxorubicin, 176
Drug delivery, 167
Drug release, 415, 422
Dual-color fluorescence cross-correlation
spectroscopy (DC-FCCS), 334
Dynamic light scattering, 18, 420
E
Elastin, native, 415
ES12, 418
Elastin-BS3 microgels, 418
Elastin-PEG DGE, 418
Electrons/O2, reversible structure/function
switching, 367
Electrostatic self-assembly and covalent
fixation (ESA-CF), 306
Emulsions, 340
solvent evaporation, 329
Encapsulation, 136
Enhanced permeability and retention
(EPR), 170
Enzymatic degradation, 421
Enzymatic polymerization, 141, 153
Epichlorohydrin/EO, 173
Ethyl 3-(alkylamino)benzoate, 204
Ethyl D-/L-lactates (EtLa)s, 159
Ethyl methacrylate (EMA), 147
Ethyl 5-(methylamino)isophthalate, 209
Ethylene oxide (EO), 171
F
Field emission scanning electron microscopy
(FESEM), 420
4-Fluoro-4’-hydroxybenzophenone, 195
4-Fluorophenyl sulfone, 195
Fuel cells, 259, 282
Fullerenes, 100
phospholipids, 100
448
Index